Gene · 1500
Papers4,443
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
261 to 280 of 4,443
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Branched-chain keto-acid dehydrogenase kinase regulates vascular permeability and angiogenesis to facilitate tumor metastasis in renal cell carcinoma. | Cancer Sci | 2023 | 37715534 | PubTator, text mining | PubMed |
| Chemoproteomic strategy identified p120-catenin glutathionylation regulates E-cadherin degradation and cell migration. | Cell Chem Biol | 2023 | 37714153 | PubTator, text mining | PubMed |
| Lumican silencing ameliorates β-glycerophosphate-mediated vascular smooth muscle cell calcification by attenuating the inhibition of APOB on KIF2C activity. | Open Med (Wars) | 2023 | 37711155 | PubTator, text mining | PubMed |
| δ-Catenin controls astrocyte morphogenesis via layer-specific astrocyte-neuron cadherin interactions. | J Cell Biol | 2023 | 37707499 | PubTator, text mining | PubMed |
| A comprehensive analysis of MYO6 as a promising biomarker for diagnosis, prognosis, and immunity in clear cell renal cell carcinoma. | Transl Cancer Res | 2023 | 37701098 | PubTator, text mining | PubMed |
| The convergent evolution of influenza A virus: Implications, therapeutic strategies and what we need to know. | Curr Res Microb Sci | 2023 | 37700857 | PubTator, text mining | PubMed |
| Therapeutic effects of medicinal plants and their constituents on lung cancer, in vitro, in vivo and clinical evidence. | J Cell Mol Med | 2023 | 37697969 | PubTator, text mining | PubMed |
| Integrated bioinformatics analysis of noncoding RNAs with tumor immune microenvironment in gastric cancer. | Sci Rep | 2023 | 37696973 | PubTator, text mining | PubMed |
| Thermosensitive hydrogel-based GPR124 delivery strategy for rebuilding blood-spinal cord barrier. | Bioeng Transl Med | 2023 | 37693060 | PubTator, text mining | PubMed |
| Frequency of CDH1, CTNNA1 and CTNND1 Germline Variants in Families with Diffuse and Mixed Gastric Cancer. | Cancers (Basel) | 2023 | 37686589 | PubTator, text mining | PubMed |
| Combining old and new concepts in targeting telomerase for cancer therapy: transient, immediate, complete and combinatory attack (TICCA). | Cancer Cell Int | 2023 | 37679807 | PubTator, text mining | PubMed |
| Non-IgE-reactive allergen peptides deteriorate the skin barrier in house dust mite-sensitized atopic dermatitis patients. | Front Cell Dev Biol | 2023 | 37675143 | PubTator, text mining | PubMed |
| Associative gene networks reveal novel candidates important for ADHD and dyslexia comorbidity. | BMC Med Genomics | 2023 | 37667328 | PubTator, text mining | PubMed |
| Linked CD4+/CD8+ T cell neoantigen vaccination overcomes immune checkpoint blockade resistance and enables tumor regression. | J Clin Invest | 2023 | 37655661 | PubTator, text mining | PubMed |
| Sex differences in brain protein expression and disease. | Nat Med | 2023 | 37653343 | PubTator, text mining | PubMed |
| Fibroblasts - the cellular choreographers of wound healing. | Front Immunol | 2023 | 37646029 | PubTator, text mining | PubMed |
| Identifying prognostic markers in spatially heterogeneous breast cancer microenvironment. | J Transl Med | 2023 | 37644433 | PubTator, text mining | PubMed |
| Nasopharyngeal carcinoma with synchronous breast metastasis: A case report. | World J Clin Cases | 2023 | 37637694 | PubTator, text mining | PubMed |
| Identification of Host PDZ-Based Interactions with the SARS-CoV-2 E Protein in Human Monocytes. | Int J Mol Sci | 2023 | 37628973 | PubTator, text mining | PubMed |
| Research Progress on Natural Small-Molecule Compounds for the Prevention and Treatment of Sepsis. | Int J Mol Sci | 2023 | 37628912 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1500/papers?page=14